Publication at First Faculty of Medicine |
2005
Abstract
Cardiogenic shock represents a complication in up to 10% of patients with acute myocardial infarction. Cardiogenic shock mortality remains high.
In the contemporary treatment inhibitors of NO synthase are studied, apart from classic medications. Mechanical circulatory support is also important in majority of patients with cardiogenic shock: intraaortic balloon contrapunction, left ventricular assist device system.
Prognosis is improved by percutaneous coronary intervention.